A case of autoimmune haemolytic anaemia after 39 cycles of nivolumab

With growing use of nivolumab, rare but serious side effects have surfaced in some patients. We present a case of autoimmune haemolytic anaemia that developed after 39 cycles of nivolumab. A 78-year-old man with metastatic lung adenocarcinoma, refractory to multiple lines of chemotherapy was switche...

Full description

Saved in:
Bibliographic Details
Published in:BMJ Case Rep
Main Authors: Shaikh, Hira, Daboul, Nour, Albrethsen, Mary, Fazal, Salman
Format: Artigo
Language:Inglês
Published: BMJ Publishing Group 2018
Subjects:
Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5911145/
https://ncbi.nlm.nih.gov/pubmed/29669775
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2018-224608
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items